© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 5X1010VP/.5ML 2 | Medium Descr | IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 2ND DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; second dose | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2022-08-31 | Note | Changes made to vaccine patient age requirements (18 yrs and older). |
| 2022-01-01 | Added | First appearance in codebook. |
| 2022-01-01 | Note | Grammar correction |
| 2022-01-01 | Changed | Code description changed. |
| 2021-01-01 | Added | First appearance of code in CPT® Code Set. |
| 2020-12-17 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |
| 2020-12-17 | Note | AMA guideline added to include 0021A, 91302; Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the FDA. |
Get instant expert-level medical coding assistance.